In this study, Met-Met significantly suppressed LPS-induced TNF-α, IL-8, AP-1, and MCP-1 expression; reversed decreased tryptophan, phenylalanine, and histidine levels; and inhibited LPS-induced palmitic acid and stearic acid levels as well as purine metabolism disorder. Here, CCL2 is linked to metabolic disease.